Trucept Adds Robbe to Board of Directors

March 1, 2021

SAN DIEGO, CA – May 21, 2021  –Trucept Inc.(OTC Pink: TREPTrucept Inc. has released its updated financials for Q1 2021. The company has experienced another consecutive quarter of profitability, as Trucept reported revenues of $3.8 million for the period (an increase from 48.76 percent over the previous year).

“We’re thrilled to have Fletcher join our Board of Directors,” said Chairman, Brian Bonar. “Securities law requires that independent members be seated on the board and he will help oversee management’s progress on the audit of Trucept’s financials,” Bonar added.

Robbe is pleased with the appointment as well and looks forward to working to grow the company. “I’m excited to be a part of this opportunity and I hope to help Trucept become an even bigger player in multiple marketplaces,” he said.

Robbe graduated from California State University Northridge with a B.A. in Political Science and received his J.D. at Southwestern University School of Law. He was admitted to the state bar of California in 1975 and formed Fletcher Robbe and Associates in 1975 which became Fletcher Robbe International Attorneys at Law in 1980. Robbe is admitted to the U.S. Federal District Court, Central District of California and the U.S. Court of Appeals, Ninth Circuit. He is also a member of the National Business Aviation Association.

For additional information, visit www.trucept.com

About Trucept Inc.

True solutions, today and tomorrow: Trucept Inc. helps organizations focus on growing their business. With a dedicated suite of powerful tools and services designed to put business owners in charge of running their businesses and increasing efficiency, Trucept tackles a variety of important administrative needs and provides a host of value-added advantages.


For more information, call 858-798-1620 or visit https://trucept.com

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.

More Recent Articles

Trucept Announces 665% Increase In Operating Income

Trucept Announces 665% Increase In Operating Income

SAN DIEGO, CA  – Augst 18th, 2023 –  Trucept Inc. (OTC Pink: TREP) Trucept has increased operating Income by 166% and 665% for the 3 and 6 months ending June 30, 2023 as compared to the same periods the prior year. Trucept has also increased Net Income by 149% and...

read more
Trucept Announces 381% Increase In Operating Income

Trucept Announces 381% Increase In Operating Income

SAN DIEGO, CA  – March 27th, 2023 –  Trucept Inc. (OTC Pink: TREP) today has released its First Quarter Financials. Trucept posted an impressive 381% increase in Operating Income, with Net Income recording a 94% increase versus the same period last year (Q1 2022). The...

read more